News

Accelerator-funded research points to potential therapy for heightened touch sensitivity in autism spectrum disorders

Based on innovations from Harvard University and Boston Children's Hospital, Nocion Therapeutics aims to selectively silence pain and itch neurons

Developed through Harvard’s Blavatnik Biomedical Accelerator, innovations could lead to novel cell therapies to treat disease

Injectable sponge-like gel enhances the quantity and quality of T-cells

New advances selectively suppress damaged cells, allowing for transplants without chemotherapy or radiation